Upgrade to SI Premium - Free Trial

Intellia Therapeutics (NTLA) PT Raised to $30 at Citizens on Data that is 'Major Milestone'

April 28, 2026 4:11 AM
Citizens analyst Silvan Turkcan raised the price target on Intellia Therapeutics (NASDAQ: NTLA) to $30.00 (from $28.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change